These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37076811)

  • 1. Global transcriptomic analysis of Francisella tularensis SchuS4 differentially expressed genes in response to doxycycline or ciprofloxacin exposure.
    Zaide G; Cohen-Gihon I; Shifman O; Israeli O; Aftalion M; Maoz S; Chitlaru T; Ber R; Zvi A; Steinberger-Levy I
    BMC Genom Data; 2023 Apr; 24(1):23. PubMed ID: 37076811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection.
    Rotem S; Bar-Haim E; Cohen H; Elia U; Ber R; Shafferman A; Cohen O
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5406-8. PubMed ID: 22850512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In Vitro Activity of Tigecycline Against Francisella tularensis Subsp. holarctica in Comparison with Doxycycline, Ciprofloxacin and Aminoglycosides].
    Ulu Kılıç A; Kılıç S; Celebi B; Sencan I
    Mikrobiyol Bul; 2013 Jan; 47(1):189-91. PubMed ID: 23390918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    Caspar Y; Hennebique A; Maurin M
    J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    Tomaso H; Hotzel H; Otto P; Myrtennäs K; Forsman M
    J Antimicrob Chemother; 2017 Sep; 72(9):2539-2543. PubMed ID: 28605439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome transcriptomics reveals global effects including up-regulation of Francisella pathogenicity island gene expression during active stringent response in the highly virulent Francisella tularensis subsp. tularensis SCHU S4.
    Murch AL; Skipp PJ; Roach PL; Oyston PCF
    Microbiology (Reading); 2017 Nov; 163(11):1664-1679. PubMed ID: 29034854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a capture-based pathogen transcript enrichment strategy for RNA-Seq analysis of the Francisella tularensis LVS transcriptome during infection of murine macrophages.
    Bent ZW; Brazel DM; Tran-Gyamfi MB; Hamblin RY; VanderNoot VA; Branda SS
    PLoS One; 2013; 8(10):e77834. PubMed ID: 24155975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Francisella tularensis subsp. tularensis induces a unique pulmonary inflammatory response: role of bacterial gene expression in temporal regulation of host defense responses.
    Walters KA; Olsufka R; Kuestner RE; Cho JH; Li H; Zornetzer GA; Wang K; Skerrett SJ; Ozinsky A
    PLoS One; 2013; 8(5):e62412. PubMed ID: 23690939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.
    Chance T; Chua J; Toothman RG; Ladner JT; Nuss JE; Raymond JL; Biot FV; Demons S; Miller L; Halasohoris S; Mou S; Koroleva G; Lovett S; Palacios G; Vietri NJ; Worsham PL; Cote CK; Kijek TM; Bozue JA
    PLoS One; 2017; 12(3):e0174106. PubMed ID: 28328947
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Caspar Y; Maurin M
    Front Cell Infect Microbiol; 2017; 7():122. PubMed ID: 28443249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
    Kiliç S; Celebi B; Acar B; Ataş M
    Scand J Infect Dis; 2013 May; 45(5):337-41. PubMed ID: 23249114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.
    Russell P; Eley SM; Fulop MJ; Bell DL; Titball RW
    J Antimicrob Chemother; 1998 Apr; 41(4):461-5. PubMed ID: 9598777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of antibiotics on Francisella tularensis].
    Sidorenko SV; Lebedeva IK; D'iakov SI; Zakharov VA
    Antibiot Khimioter; 1992 Nov; 37(11):14-7. PubMed ID: 1300925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe.
    Kreizinger Z; Makrai L; Helyes G; Magyar T; Erdélyi K; Gyuranecz M
    J Antimicrob Chemother; 2013 Feb; 68(2):370-3. PubMed ID: 23065699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo.
    Chase JC; Bosio CM
    Infect Immun; 2010 Jan; 78(1):154-67. PubMed ID: 19841074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
    Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
    Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the putative transcriptional regulator IclR on Francisella tularensis pathogenesis.
    Mortensen BL; Fuller JR; Taft-Benz S; Kijek TM; Miller CN; Huang MT; Kawula TH
    Infect Immun; 2010 Dec; 78(12):5022-32. PubMed ID: 20921148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents.
    Scheel O; Hoel T; Sandvik T; Berdal BP
    APMIS; 1993 Jan; 101(1):33-6. PubMed ID: 8384458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a Francisella tularensis-Caenorhabditis elegans Pathosystem for the Evaluation of Therapeutic Compounds.
    Jayamani E; Tharmalingam N; Rajamuthiah R; Coleman JJ; Kim W; Okoli I; Hernandez AM; Lee K; Nau GJ; Ausubel FM; Mylonakis E
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652232
    [No Abstract]   [Full Text] [Related]  

  • 20. A Rapid Molecular Test for Determining Yersinia pestis Susceptibility to Ciprofloxacin by the Quantification of Differentially Expressed Marker Genes.
    Steinberger-Levy I; Shifman O; Zvi A; Ariel N; Beth-Din A; Israeli O; Gur D; Aftalion M; Maoz S; Ber R
    Front Microbiol; 2016; 7():763. PubMed ID: 27242774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.